PatientsVille.com Logo

PatientsVille
Topamax Side Effects

Report Topamax Side Effects

If you experienced any harmful or unwanted effects of Topamax, please share your experience. This could help to raise awareness about Topamax side effects, identify uknown risks and inform health professionals and patients taking Topamax.

Examples: headache, dizziness


The most commonly reported Topamax side effects are:
Short Term Memory Confusion (35 reports)
Tingling In Extremities (32 reports)
Hair Loss (24 reports)
Taste Changes (21 reports)
Weight (21 reports)
Confusion (21 reports)
Cold (20 reports)
Vision Floaters (15 reports)
Weight Loss (14 reports)
Chest Pain (11 reports)
Sleepiness (7 reports)
Itching (6 reports)

If you have experienced a side effect listed above, you can check a box to report it.


View a complete list of Topamax side effects or compare Topamax side effects

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (eg, physician, pharmacist). Your health care provider can provide additional clinical information and complete a copy of the side effect reporting form.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

'

Topamax Side Effects Reported to FDA

The following Topamax reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Topamax on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Loss Of Consciousness
on Feb 04, 2014 Female from RU , 61 years of age, was treated with Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: loss of consciousness. Topamax dosage: N/A.
Associated medications used:
  • Carbamazepine
Patient was hospitalized.

Epilepsy
Patient was taking Topamax. Patient felt the following Topamax side effects: epilepsy on Mar 03, 2014 from RU Additional patient health information: Female , 37 years of age, . Topamax dosage: N/A.

Pancreatic Enzymes Increased, Arthralgia, Diarrhoea, Pyrexia, Weight Decreased
Adverse event was reported on Jan 31, 2014 by a Female taking Topamax (Dosage: N/A) was diagnosed with and. Location: IT , 35 years of age, After Topamax was administered, patient encountered several Topamax side effects: pancreatic enzymes increased, arthralgia, diarrhoea, pyrexia, weight decreased. Patient was hospitalized.

Epilepsy, Depression, Substance Abuse, Decreased Appetite, Weight Decreased
on Jan 31, 2014 Female from BE , 18 years of age, was diagnosed with and was treated with Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: epilepsy, depression, substance abuse, decreased appetite, weight decreased. Topamax dosage: A Handful Of 10.
Associated medications used:
  • Lyrica
  • Sipralexa
  • Trazolan
Patient was hospitalized.


Epilepsy
on Mar 05, 2014 Male from RU , child 12 years of age, was treated with Topamax. Patient felt the following Topamax side effects: epilepsy. Topamax dosage: N/A.
Multiple prescriptions taken:
  • Valproic Acid
  • Lamotrigine


Glaucoma
Patient was taking Topamax. After Topamax was administered, patient encountered several Topamax side effects: glaucoma on Jan 23, 2014 from US Additional patient health information: Male , 24 years of age, weighting 225.0 lb, . Topamax dosage: 1 Pill Once Daily Taken By Mouth. Patient was hospitalized and became disabled.

Suicide Attempt, Aggression, Intentional Overdose, Bipolar I Disorder, Mood Altered
Adverse event was reported on Jan 23, 2014 by a Male taking Topamax (Dosage: N/A) . Location: GB , 27 years of age, weighting 174.2 lb, Directly after, patient experienced the unwanted or unexpected Topamax side effects: suicide attempt, aggression, intentional overdose, bipolar i disorder, mood altered. Patient was hospitalized.

Loss Of Consciousness, Hypertension, Off Label Use, Dysstasia, Blood Glucose Decreased, Eating Disorder, Hypoaesthesia, Sensory Disturbance, Confusional State
on Jan 23, 2014 Female from US , 43 years of age, weighting 234.0 lb, was diagnosed with and was treated with Topamax. Patient felt the following Topamax side effects: loss of consciousness, hypertension, off label use, dysstasia, blood glucose decreased, eating disorder, hypoaesthesia, sensory disturbance, confusional state. Topamax dosage: N/A.
Multiple prescriptions taken:
  • Armour Thyroid


Coma, Hypotension
on Mar 04, 2014 Female from IT , 39 years of age, was diagnosed with and was treated with Topamax. After Topamax was administered, patient encountered several Topamax side effects: coma, hypotension. Topamax dosage: N/A.
Multiple concurrent drugs taken:
  • Carbolithium
  • Triazolam
  • Talofen
  • Delorazepam


Loss Of Consciousness, Altered State Of Consciousness, Chest Pain, Hypertension, Incorrect Dose Administered, Musculoskeletal Pain, Chest Discomfort, Dyspnoea
Patient was taking Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: loss of consciousness, altered state of consciousness, chest pain, hypertension, incorrect dose administered, musculoskeletal pain, chest discomfort, dyspnoea on Jan 23, 2014 from US Additional patient health information: Female , 43 years of age, weighting 243.0 lb, was diagnosed with and. Topamax dosage: N/A.

Amnesia, Hallucination, Auditory, Hallucination, Olfactory
Adverse event was reported on Jan 22, 2014 by a Male taking Topamax (Dosage: N/A) was diagnosed with and. Location: PL , 21 years of age, Patient felt the following Topamax side effects: amnesia, hallucination, auditory, hallucination, olfactory. Patient was hospitalized.

Cerebrovascular Accident, Epilepsy
on Jan 09, 2014 Female from US , 31 years of age, weighting 160.0 lb, was diagnosed with and was treated with Topamax. After Topamax was administered, patient encountered several Topamax side effects: cerebrovascular accident, epilepsy. Topamax dosage: N/A. Patient was hospitalized.

Self Injurious Behaviour, Intentional Overdose, Vertigo, Paraesthesia, Nausea, Acidosis Hyperchloraemic
on Feb 03, 2014 Female from IT , 46 years of age, weighting 132.3 lb, was diagnosed with and was treated with Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: self injurious behaviour, intentional overdose, vertigo, paraesthesia, nausea, acidosis hyperchloraemic. Topamax dosage: N/A.

Convulsion, Laceration, Migraine
Patient was taking Topamax. Patient felt the following Topamax side effects: convulsion, laceration, migraine on Jan 07, 2014 from US Additional patient health information: Male , weighting 220.0 lb, was diagnosed with and. Topamax dosage: N/A. Patient was hospitalized.

Suicidal Ideation, Anger
Adverse event was reported on Jan 02, 2014 by a Female taking Topamax (Dosage: N/A) . Location: US , 34 years of age, After Topamax was administered, patient encountered several Topamax side effects: suicidal ideation, anger.
Multiple concurrent drugs taken:
  • Copaxone
Patient was hospitalized.

Personality Change, Social Avoidant Behaviour, Hostility, Irritability, Morose, Memory Impairment, Vision Blurred, Cognitive Disorder, Thinking Abnormal
on Dec 30, 2013 Male from US , 43 years of age, weighting 250.0 lb, was treated with Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: personality change, social avoidant behaviour, hostility, irritability, morose, memory impairment, vision blurred, cognitive disorder, thinking abnormal. Topamax dosage: 1/2 Pill, Twice Daily, Taken By Mouth.

Chronic Obstructive Pulmonary Disease, Depression, Benign Prostatic Hyperplasia, Type 2 Diabetes Mellitus, Neuropathy Peripheral, Erectile Dysfunction, Deafness, Impaired Gastric Emptying, Migraine With Aura
on Dec 26, 2013 Male from US , 51 years of age, was treated with Topamax. Patient felt the following Topamax side effects: chronic obstructive pulmonary disease, depression, benign prostatic hyperplasia, type 2 diabetes mellitus, neuropathy peripheral, erectile dysfunction, deafness, impaired gastric emptying, migraine with aura. Topamax dosage: N/A.
Multiple prescriptions taken:
  • Keflex
  • Flexeril
  • Cymbalta
  • Daliresp
  • Norco (7.5 Mg/325 Mg Per Tablet)
  • Lovaza
  • Reglan
  • Nicotrol


Foetal Growth Restriction, Foetal Exposure During Pregnancy
Patient was taking Topamax. After Topamax was administered, patient encountered several Topamax side effects: foetal growth restriction, foetal exposure during pregnancy on Dec 26, 2013 from CH Additional patient health information: Male , weighting 5.95 lb, was diagnosed with and. Topamax dosage: N/A. Patient was hospitalized.

Intentional Overdose, Self Injurious Behaviour, Syncope
Adverse event was reported on Feb 07, 2014 by a Female taking Topamax (Dosage: 8 Plus 20 Capsules (700 Mg In Total)) . Location: IT , 20 years of age, Directly after, patient experienced the unwanted or unexpected Topamax side effects: intentional overdose, self injurious behaviour, syncope.

Hospitalisation, Weight Decreased
on Dec 18, 2013 Female from NL , 43 years of age, weighting 136.7 lb, was diagnosed with and was treated with Topamax. Patient felt the following Topamax side effects: hospitalisation, weight decreased. Topamax dosage: N/A.
Multiple prescriptions taken:
  • Pantoprazol
  • Salbutamol Sulfate
  • Phenytoin Sodium
Patient was hospitalized.

Visual Acuity Reduced, Balance Disorder, Hypoaesthesia, Visual Field Defect, Discomfort
on Dec 17, 2013 Female from SE , 26 years of age, was treated with Topamax. After Topamax was administered, patient encountered several Topamax side effects: visual acuity reduced, balance disorder, hypoaesthesia, visual field defect, discomfort. Topamax dosage: 25 Mg X 3 Tablets At Night.
Multiple concurrent drugs taken:
  • Concerta
  • Concerta
  • Sobril
  • Imovane
  • Theralen
  • Heminevrin
  • Heminevrin
  • Fluoxetine


Product Counterfeit, Dizziness
Patient was taking Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: product counterfeit, dizziness on Dec 16, 2013 from CN Additional patient health information: Female , 30 years of age, was diagnosed with and. Topamax dosage: 25 Mg X 60 Tablets.

Impaired Work Ability
Adverse event was reported on Dec 05, 2013 by a Male taking Topamax (Dosage: N/A) was diagnosed with and. Location: DE , 49 years of age, Patient felt the following Topamax side effects: impaired work ability.

Confusional State, Agitation, Intentional Overdose, Repetitive Speech
on Dec 02, 2013 Female from IT , 17 years of age, was treated with Topamax. After Topamax was administered, patient encountered several Topamax side effects: confusional state, agitation, intentional overdose, repetitive speech. Topamax dosage: N/A.

Inappropriate Affect
on Nov 26, 2013 Male from ES , child 6 years of age, was diagnosed with and was treated with Topamax. Directly after, patient experienced the unwanted or unexpected Topamax side effects: inappropriate affect. Topamax dosage: N/A.

1 of 150 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Topamax Side Effects

    Did You Have a Topamax Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Topamax for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative TOPAMAX Names:TOPIRAMAT

    Active Ingredient: TOPIRAMAT

    Topamax Dosage, Warnings, Usage.

    Side Effects reported to FDA: 3748

    Topamax safety alerts: 2011 2005 2003 2001

    Reported deaths: 156

    Reported hospitalizations: 1102

    Topamax (topiramate): Recall - Musty Odor

    [Posted 04/15/2011]

    AUDIENCE: Risk Manager, Pharmacy, Patients

    ISSUE: Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is recalling two lots of Topamax (topiramate) 100mg Tablets. The recall stems from four consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole). While not considered to be toxic, TBA can generate an offensive odor and a small number of patients have reported temporary gastrointestinal symptoms. There have been no reported serious adverse events caused by the presence of TBA in Topamax.

    BACKGROUND: Topamax is indicated as initial monotherapy in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures; as adjunctive therapy for adults and pediatric patients ages 2 − 16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome; and for adults for the prophylaxis of migraine headache.

    RECOMMENDATION: Patients taking Topamax 100mg Tablets who experience an uncharacteristic odor associated with their medication should return the tablets to their pharmacist, and contact their healthcare professional if they have questions.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [04/14/2011 - Press Release - Ortho-McNeil]

    Latest Topamax clinical trials